MY151447A - Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke - Google Patents

Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

Info

Publication number
MY151447A
MY151447A MYPI20041567A MYPI20041567A MY151447A MY 151447 A MY151447 A MY 151447A MY PI20041567 A MYPI20041567 A MY PI20041567A MY PI20041567 A MYPI20041567 A MY PI20041567A MY 151447 A MY151447 A MY 151447A
Authority
MY
Malaysia
Prior art keywords
stroke
treatment
intravenous injection
plasminogen activators
neurotoxic plasminogen
Prior art date
Application number
MYPI20041567A
Inventor
Söhngen Mariola
Söhngen Wolfgang
Schleuning Wolf-Dieter
Medcalf Robert
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of MY151447A publication Critical patent/MY151447A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

THE INVENTION REFERS TO THE USE OF NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS, E.G. FROM DESMODUS ROTUNDUS (DSPA) OR OF GENETICALLY MODIFIED PLASMINOGEN ACTIVATING FACTORS, IN PARTICULAR OF HUMAN ORIGIN, FOR THE PRODUCTION OF A PHARMACEUTICAL FOR INJECTION FOR THE THERAPEUTIC TREATMENT OF STROKE IN HUMANS.
MYPI20041567A 2003-05-02 2004-04-30 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke MY151447A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EPPCT/EP03/04608 2003-05-02
PCT/EP2003/004729 WO2004096267A1 (en) 2003-05-02 2003-05-06 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

Publications (1)

Publication Number Publication Date
MY151447A true MY151447A (en) 2014-05-30

Family

ID=33395696

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20041567A MY151447A (en) 2003-05-02 2004-04-30 Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

Country Status (14)

Country Link
JP (1) JP2012077090A (en)
CN (1) CN1849133B (en)
AU (3) AU2003227721A1 (en)
CY (1) CY1114254T1 (en)
DK (1) DK1622639T3 (en)
EA (2) EA013837B1 (en)
ES (1) ES2401782T3 (en)
HK (1) HK1092045A1 (en)
IL (1) IL171636A (en)
MY (1) MY151447A (en)
PT (1) PT1622639E (en)
SI (1) SI1622639T1 (en)
WO (1) WO2004096267A1 (en)
ZA (2) ZA200703704B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10153601A1 (en) 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke
TWI445540B (en) 2007-04-20 2014-07-21 Ajinomoto Kk Anti-hypothermia composition
AR067345A1 (en) * 2007-07-10 2009-10-07 Paion Deutschland Gmbh USE OF THROMBOMODULIN FOR THE PREPARATION OF A THROMBOLITIC MEDICINAL PRODUCT
EP2014296A1 (en) * 2007-07-10 2009-01-14 PAION Deutschland GmbH Novel strategies for increasing the reperfusion in obstructed blood vessel

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI100403B (en) * 1988-07-20 1997-11-28 Schering Ag Process for Preparation of Glycocylated or Glycocylated Pla Sminogen Activators of Vampire Bats Saliva
NL8902454A (en) * 1989-10-03 1991-05-01 Stichting Centraal Lab MUTANTS OF THE HUMANE PLASMINOGENIC ACTIVATOR INHIBITOR 1 (PAI-1), THEIR PREPARATION AND USE, AND RECOMBINANT POLYNUCLEOTIDES INCLUDING GENETIC INFORMATION CODING FOR THESE MUTANTS.
HU218830B (en) * 1991-09-05 2000-12-28 Schering Ag. Process for producing collagen-induced platelet aggregation inhibitor
DE10153601A1 (en) * 2001-11-02 2003-05-22 Paion Gmbh DSPA for the treatment of stroke

Also Published As

Publication number Publication date
AU2004233601B2 (en) 2009-11-26
DK1622639T3 (en) 2013-04-15
WO2004096267A1 (en) 2004-11-11
JP2012077090A (en) 2012-04-19
EA200501733A1 (en) 2006-06-30
AU2003227721A1 (en) 2004-11-23
EA013837B1 (en) 2010-08-30
IL171636A (en) 2013-07-31
ZA200509053B (en) 2007-11-28
AU2004233601A1 (en) 2004-11-11
PT1622639E (en) 2013-04-01
CY1114254T1 (en) 2016-08-31
SI1622639T1 (en) 2013-05-31
EA201000501A1 (en) 2010-10-29
ES2401782T3 (en) 2013-04-24
CN1849133B (en) 2011-03-30
HK1092045A1 (en) 2007-02-02
CN1849133A (en) 2006-10-18
AU2010200718A1 (en) 2010-03-18
ZA200703704B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
NO20055692L (en) Intravenous injection of non-neurotoxic plasminogen activators for the treatment of cerebral stroke
CY1109648T1 (en) NON-NEUROTOTOXIC PLASMINOGEN ACTIVATORS FACTORS FOR BRAIN INTERVENTION
MX2007003031A (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases.
DE60111570D1 (en) ISOINDOLIN-1-ON AS GLUCOKINASE ACTIVATORS
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
ZA200107495B (en) N-cyanomethyl amides as protease inhibitors.
MXPA05008406A (en) Phenylacetamides and their use as glucokinase modulators.
EA200401525A1 (en) METHODS OF TREATMENT OF HEPATITIS (OPTIONS)
IL171607A (en) Use of a botulinum toxin for the preparation of a medicament for treating sinus headache
MX2007003907A (en) Therapeutic agents with decreased toxicity.
WO2005074904A3 (en) Silinane compounds as cysteine protease inhibitors
MXPA04004306A (en) Use of endothelin receptor antagonists in the treatment of tumour diseases.
UA90504C2 (en) Novel drugs for treating respiratory diseases
YU68702A (en) Novel lhrh-antagonists, production and use thereof as medicament
CY1114254T1 (en) Intravenous injection of non-neurotoxic plasminogen activators to treat cerebral episode
IL151647A0 (en) Novel lhrh-antagonists, production and use thereof as medicament
AU2002365288A1 (en) Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
NZ533738A (en) Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis
IL165996A0 (en) Novel thiophene acyl hydrazino derivatives method for preparing same use thereof as medicines pharmaceutical compositions and novel use
UA90843C2 (en) Tri(cyclo) substituted amide compounds
ITMI20041822A1 (en) "USEFUL THERAPEUTIC AGENT FOR THE TREATMENT OF PLASMACELLULAR NEOPLASIES"
MX2007004040A (en) Novel use of -sympathomimetics having a 2-imidazoline structure.